Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice

被引:93
作者
Murosaki, S
Muroyama, K
Yamamoto, Y
Yoshikai, Y
机构
[1] Takeda Chem Ind Ltd, Pharmaceut Res Labs 2, Yodogawa Ku, Osaka 5328686, Japan
[2] Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Lab Host Def,Showa Ku, Nagoya, Aichi 4668550, Japan
[3] Takeda Food Prod Ltd, Res & Dev Sect, Itami, Hyogo 6640011, Japan
关键词
Lactobacillus plantarum; IL-12; antitumor immunity;
D O I
10.1007/s002620050615
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have previously reported that heat-killed Lactobacillus plantarum L-137 is a potent inducer of interleukin-13 (IL-12) in vivo as well as in vitro in mice. In order to develop effective usage of L. plantarum L-137 for tumor immunotherapy, we examined its antitumor effect against DBA/2 mice inoculated with syngenic P388D1 tumor cells in different treatment schedules. Daily injection of L. plantarum L-137 from the day of tumor inoculation induced a steep increase in plasma IL-12 only after the first injection but not after subsequent injections, and had no effect on tumor growth and survival time. In contrast, daily injection of L. plantarum L-137 from the 7th day after tumor inoculation exerted a marked antitumor effect but such an effect was not evident in mice treated with L. plantarum L-137 twice a week from the 7th day. IL-12 production was considerably impaired at the first injection but steeply increased after the third injection in the mice injected daily with L. plantarum L-137 from the 7th day, Our results suggest that daily administration of L. plantarum L-137 is required to exert an antitumor effect at the late stages of tumor development when IL-12 production is considerably impaired.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 31 条
[1]   HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A POTENT INHIBITOR OF ANGIOGENESIS IN-VIVO [J].
ANGIOLILLO, AL ;
SGADARI, C ;
TAUB, DD ;
LIAO, F ;
FARBER, JM ;
MAHESHWARI, S ;
KLEINMAN, HK ;
REAMAN, GH ;
TOSATO, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :155-162
[2]   ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].
ARTEAGA, CL ;
HURD, SD ;
WINNIER, AR ;
JOHNSON, MD ;
FENDLY, BM ;
FORBES, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576
[3]   ENHANCING EFFECT OF NATURAL-KILLER-CELL STIMULATORY FACTOR (NKSF/INTERLEUKIN-12) ON CELL-MEDIATED CYTOTOXICITY AGAINST TUMOR-DERIVED AND VIRUS-INFECTED CELLS [J].
CHEHIMI, J ;
VALIANTE, NM ;
DANDREA, A ;
RENGARAJU, M ;
ROSADO, Z ;
KOBAYASHI, M ;
PERUSSIA, B ;
WOLF, SF ;
STARR, SE ;
TRINCHIERI, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) :1826-1830
[4]   The host-tumor immune conflict: from immunosuppression to resistance and destruction [J].
Chouaib, S ;
AsselinPaturel, C ;
MamiChouaib, F ;
Caignard, A ;
Blay, JY .
IMMUNOLOGY TODAY, 1997, 18 (10) :493-497
[5]   Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization [J].
Claessen, AME ;
vonBlomberg, BME ;
deGroot, J ;
Wolvers, DAE ;
Kraal, G ;
Scheper, RJ .
IMMUNOLOGY, 1996, 88 (03) :363-367
[6]  
DANDREA A, 1993, J EXP MED, V178, P104
[7]  
ESPINOZADELGADO I, 1994, BLOOD, V83, P3332
[8]  
Fujimoto T, 1997, J IMMUNOL, V158, P5619
[9]   ADMINISTRATION OF RECOMBINANT IL-12 TO NORMAL MICE ENHANCES CYTOLYTIC LYMPHOCYTE ACTIVITY AND INDUCES PRODUCTION OF IFN-GAMMA IN-VIVO [J].
GATELY, MK ;
WARRIER, RR ;
HONASOGE, S ;
CARVAJAL, DM ;
FAHERTY, DA ;
CONNAUGHTON, SE ;
ANDERSON, TD ;
SARMIENTO, U ;
HUBBARD, BR ;
MURPHY, M .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (01) :157-167
[10]   A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES [J].
GEHAN, EA .
BIOMETRIKA, 1965, 52 :203-+